Is Intravascular Ultrasound the Gold Standard Surrogate for Clinically Relevant Atherosclerosis Progression?

Journal of the American College of Cardiology

Volumn 49, Issue 9, 2007, Pages 933-938

  Brown, B Greg ^a   Zhao, Xue Qiao ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOGRAPHY; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; DISEASE COURSE; EVIDENCE BASED PRACTICE; HUMAN; INTERMETHOD COMPARISON; INTRAVASCULAR ULTRASOUND; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT;

CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DISEASE PROGRESSION; EVIDENCE-BASED MEDICINE; HUMANS; RESEARCH DESIGN; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33847310317     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.12.014     Document Type: Review

References (43)

1. Pope A. Essay on Criticism, Part II. 1711.
2. Böse D., von Birgelen C., and Erbel R. Intravascular ultrasound for the evaluation of therapies targeting coronary atherosclerosis. J Am Coll Cardiol 49 (2007) 925-932
3. Nissen S.E., and Yock P.G. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. (review). Circulation 103 (2001) 604-616
4. Mintz G.S., Nissen S.E., Anderson W.D., et al. American College of Cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 37 (2001) 1478-1492
5. Brown B.G., Bolson E., Frimer M., and Dodge H.T. Quantitative coronary arteriography: estimation of dimensions, hemodynamic resistance, and atheroma mass of coronary artery lesions using the arteriogram and digital computation. Circulation 55 (1977) 329-337
6. Serruys P.W., Reiber J.H., Wijns W., et al. Assessment of percutaneous transluminal coronary angioplasty by quantitative coronary angiography: diameter versus densitometric area measurements. Am J Cardiol 54 (1984) 482-488
7. Mancini G.B., Simon S.B., McGillem M.J., et al. Automated quantitative coronary arteriography: morphologic and physiologic validation in vivo of a rapid digital angiographic method. (erratum in Circulation 1987;75:1199). Circulation 75 (1987) 452-460
8. Glagov S., Weisenberg E., Zarins C.K., et al. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 316 (1987) 1371-1375
9. Kragel A.H., Reddy S.G., Wittes J.T., and Roberts W.C. Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarction and in sudden coronary death. Circulation 80 (1989) 1747-1756
10. Brown B.G., Gallery C.A., Badger R.S., et al. Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observations. Circulation 73 (1986) 653-661
11. Davies M.J., Richardson P.D., Woolf N., Katz D.R., and Mann J. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 69 (1993) 377-381
12. Virmani R., Burke A.P., Farb A., and Kolodgie F.D. Pathology of the vulnerable plaque. J Am Coll Cardiol 47 Suppl (2006) C13-C18
13. Libby P., and Theroux P. Pathophysiology of coronary artery disease. (review). Circulation 111 (2005) 3481-3488
14. Brown B.G., Hillger L.A., Lewis C., et al. A maximum confidence approach for measuring progression and regression of coronary artery disease in clinical trials. Circulation 87 Suppl II (1993) II66-II73 Epidemiology
15. Reiber J.H., Serruys P.W., Kooijman C.J., et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 71 (1985) 280-288
16. Brown B.G., Sacco D., Zhao X.-Q., and Albers J.J. Lipid-lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. Clinical Progress Series. Circulation 87 (1993) 1781-1791
17. Brown B.G., Albers J.J., Fisher L.D., et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323 (1990) 1289-1298
18. Brown B.G., Zhao X.-Q., Chait A., et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 345 (2001) 1583-1592
19. Nissen S.E., Tuczu E.M., Schoenhagen P., et al. Effect of intensive compared with moderate lipid-lowering on progression of coronary atherosclerosis. JAMA 291 (2004) 1071-1080
20. Nissen S.E., Tsunoda T., Tuzcu E.M., et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA 290 (2003) 2292-2300
21. Nissen S.E., Tuzcu E.M., Libby P., et al., CAMELOT Investigators. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 292 (2004) 2217-2225
22. Nissen S.E., Nicholls S.J., Sipahi I., et al., ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA 295 (2006) 1556-1565
23. Sipahi I., Tuzcu E.M., Schoenhagen P., et al. Compensatory enlargement of human coronary arteries during progression of atherosclerosis is unrelated to atheroma burden: serial intravascular ultrasound observations from the REVERSAL trial. Eur Heart J 27 (2006) 1664-1670
24. Nicholls S.J., Tuzcu E.M., Sipahi I., et al. Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano. J Am Coll Cardiol 47 (2006) 992-997
25. Nair A., Kuban B.D., Tuzcu E.M., et al. Coronary plaque classification with intravascular ultrasound radiofrequency data analysis. Circulation 106 (2002) 2200-2206
26. Komiyama N., Berry G.J., Kolz M.L., et al. Tissue characterization of atherosclerotic plaques by intravascular ultrasound radiofrequency signal analysis: an in vitro study of human coronary arteries. Am Heart J 140 (2000) 565-574
27. Mann J.M., and Davies M.J. Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries. Circulation 94 (1996) 928-931
28. Waters D., Craven T.E., and Lesperance J. Prognostic significance of progression of coronary atherosclerosis. Circulation 87 (1993) 1067-1075
29. Buchwald H., Matts J.P., Fitch L.L., et al., Surgical Control of the Hyperlipidemias (POSCH) Group. Changes in sequential coronary arteriograms and subsequent coronary events. JAMA 268 (1992) 1429-1433
30. Azen S.P., Mack W.J., Cashin-Hemphill L., et al. Progression of coronary artery disease predicts clinical coronary events. Long-term follow-up from the Cholesterol Lowering Atherosclerosis Study. Circulation 93 (1996) 34-41
31. Tuzcu E.M., Kapadia S.R., Sachar R., et al. Intravascular ultrasound evidence of angiographically silent progression in coronary atherosclerosis predicts long-term morbidity and mortality after cardiac transplantation. J Am Coll Cardiol 45 (2005) 1538-1542
32. von Birgelen C., Hartmann M., Mintz G.S., et al. Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries. Circulation 110 (2004) 1579-1585
33. Pitt B., Mancini G.B., Ellis S.G., et al. Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events. PLAC I investigation. J Am Coll Cardiol 26 (1995) 1133-1139
34. Waters D., Higginson L., Gladstone P., et al. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. Circulation 89 (1994) 959-968
35. Blankenhorn D.H., Azen S.P., Kramsch D.M., et al., MARS Research Group. Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS)Ann Intern Med 119 (1993) 969-976
36. The MAAS Investigators. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet 344 (1994) 633-638
37. Jukema J.W., Bruschke A.V., van Boven A.J., et al. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 91 (1995) 2528-2540
38. Herd J.A., Ballantyne C.M., Farmer J.A., et al. Effects of fluvastatin on coronary atherosclerosis in patients with mild to moderate cholesterol elevations (Lipoprotein and Coronary Atherosclerosis Study [LCAS]). Am J Cardiol 80 (1997) 278-286
39. Whitney E.J., Krasuski R.A., Personius B.E., et al. A randomized trial of a strategy for increasing high-density lipoprotein cholesterol levels: effects on progression of coronary heart disease and clinical events. Ann Intern Med 142 (2005) 95-104
40. Brown B.G., Hillger L., Zhao X.-Q., et al. Types of change in coronary stenosis severity and their relative importance in overall progression and regression of coronary disease: observations from the FATS trial. Ann N Y Acad Sci 748 (1995) 1407-1417
41. Zhao X.-Q., Yuan C., Hatsukami T.S., et al. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI. Arterioscler Thromb Vasc Biol 21 (2001) 1623-1629
42. Tardif J.C., Gregoire J., L'Allier P.L., et al., Avasimibe and Progression of Lesions on UltraSound (A-PLUS) Investigators. Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation 110 (2004) 3372-3377
43. Tobis J., and Colombo A. IVUS and coronary stenting. Cathet Cardiovasc Diagn 39 (1996) 346